本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2014/3/101 分钟阅读
MK Laboratories, Inc., et al.; Proposal To Withdraw Approval of Three Abbreviated New Drug Applications for Propoxyphene Products; Opportunity for a Hearing
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) is proposing to withdraw approval of three abbreviated new drug applications (ANDAs) for propoxyphene drug products from multiple sources and is announcing an opportunity for holders of those ANDAs to request a hearing on this proposal.
来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →